1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Clozapine is the gold-standard medicine for treating refractory schizophrenia but there are some notable serious adverse events (AE). We aimed to analyse reported rates of clozapine cardiac and haematological AEs in Australia.

          Related collections

          Author and article information

          Journal
          Psychopharmacology (Berl.)
          Psychopharmacology
          Springer Nature
          1432-2072
          0033-3158
          Jul 2018
          : 235
          : 7
          Affiliations
          [1 ] School of Pharmacy, The University of Queensland, 20 Cornwall St, Woolloongabba, QLD, 4102, Australia. s.hollingworth@uq.edu.au.
          [2 ] School of Pharmacy, The University of Queensland, 20 Cornwall St, Woolloongabba, QLD, 4102, Australia.
          [3 ] Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba, QLD, 4102, Australia.
          [4 ] School of Public Health, The University of Queensland, Herston Rd, Herston, QLD, 4006, Australia.
          [5 ] Menzies Health Institute Queensland, Meadowbrook, QLD, 4103, Australia.
          [6 ] Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, New Zealand.
          [7 ] SA Pathology, PO Box 14 Rundle Mall, Adelaide, SA, 5000, Australia.
          [8 ] Metro South Addiction and Mental Health Service, 228 Logan Road, Woolloongabba, QLD, 4102, Australia.
          [9 ] School of Medicine, The University of Queensland, Herston Rd, Herston, QLD, 4006, Australia.
          Article
          10.1007/s00213-018-4881-0
          10.1007/s00213-018-4881-0
          29589067
          87141d95-db2e-450e-8142-3255158e0cef
          History

          Pharmacovigilance,Adverse events,Agranulocytosis,Clozapine,Myocarditis cardiomyopathy,Neutropenia

          Comments

          Comment on this article